CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin-Reference-Cited by-同舟云学术

CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin

Published:2019-08-31 Issue:11 Volume:145 Page:3112-3125
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Galaine Jeanne¹^ORCID,Turco Célia¹²,Vauchy Charline³,Royer Bernard¹⁴,Mercier‐Letondal Patricia¹,Queiroz Lise³,Loyon Romain¹,Mouget Virginie¹,Boidot Romain⁵,Laheurte Caroline¹⁶,Lakkis Zaher¹²,Jary Marine¹⁷,Adotévi Olivier¹⁷^ORCID,Borg Christophe¹⁷,Godet Yann¹

Affiliation:

1. Univ. Bourgogne Franche‐Comté, INSERM, EFS BFC, UMR1098Interactions Hôte‐Greffon‐Tumeur/Ingénierie Cellulaire et Génique Besançon France

2. University Hospital of BesançonDepartment of Gastrointestinal Surgery Besançon France

3. INSERM CIC‐1431, University Hospital of Besançon, Clinical Investigation Center un BiotherapyFédération Hospitalo‐Universitaire INCREASE, LabEx LipSTIC Besançon France

4. University Hospital of BesançonDepartment of pharmacotoxicology Besançon France

5. Centre Georges‐François LeclercPlatform for Transfer to Cancer Biology Dijon France

6. EFS Bourgogne Franche‐Comté, INSERM CIC‐1431, CHRU BesançonPlateforme de BioMonitoring Besançon France

7. University Hospital of BesançonDepartment of Medical Oncology Besançon France

Funder

Ligue Contre le Cancer

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32620

Reference50 articles.

1. Colorectal cancer: From prevention to personalized medicine

2. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis

3. Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases

4. Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

5. Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer;International Immunopharmacology;2024-09

2. New approach in Understanding Colorectal Cancer Immunosuppression and Immunotherapy-Based Strategies in the Treatment of Microsatellite Stable Colorectal Cancer;Acta Medica Bulgarica;2024-06-01

3. Cancer immunometabolism: advent, challenges, and perspective;Molecular Cancer;2024-04-05

4. Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implications;Cancer Cell International;2024-03-12

5. Predictive response and outcome of peripheral CD4+ T cell subpopulations to combined immunotherapy and chemotherapy in advanced gastric cancer patients;International Immunopharmacology;2024-03